Error in Figure
In the original publication [1], Figure 4 contained an error introduced during the production process. The corrected version of Figure 4 is provided below. Specifically, there was image duplication in Figure 4B (column, 9 dpi, rows ISO and CCL2, and column, 30 dpi, rows ISO and CCL2). The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 4.
Effect of CCL2 on HIV-1 subtype C and B replication in MDMs. (A) MDMs were infected with HIV-1IndieC1-mGL reporter virus (Left) or HIV-1NLAD8-GFP-Nef (Right) and treated with CCL2, anti-CCL2, or isotype control antibody (see Methods). UT = no treatment. (B) Tracking the effect of CCL2 or anti-CCL2 on HIV-1IndieC1-mGL reporter replication via fluorescence intensity. (C) Tracking the effect of CCL2 or anti-CCL2 on HIV-1NLAD8-GFP-Nef replication in MDMs using fluorescence intensity. dpi, days post infection. Scale bar for (B,C) is as in the panel anti-CCL2, 30 dpi. (D) Measurement of fluorescence intensity in panels (B,C) for subtype C or subtype B reporter viruses with various treatments. Data are a mean of three experiments ± SEM (n = 3).
Reference
- Mofed, D.; Mandarino, A.; Wu, X.; Lang, Y.; Gowripalan, A.; Kalpana, G.V.; Prasad, V.R. Construction of a Macrophage-Tropic Subtype C HIV-1-mGreenLantern Reporter Virus for Studies on HIV-1 Replication and the Impact of Methamphetamine. Viruses 2024, 16, 1859. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.